The current AMR landscape in China and how the healthcare systems and national action plan operate in practice – by Tao Chen and Yonghong ...
more
Personalized phage therapy at scale: Why cost-effective infrastructure is the missing link – by José C. Santos and José L. Bila
more
Beyond approval: Building a coordinated, adaptive evidence ecosystem for novel antibiotics – by Ursula Theuretzbacher
more
From fixed courses to flexible care – reconsidering antifungal treatment duration and route – by Ilana Reinhold, Rosanne Sprute, ...
more
The global relevance of NDM variants in antimicrobial resistance – by Clarisa Parodi and Alejandro J. Vila
more
Volcano at the molecular level: The unprecedented rise of multidrug-resistant Enterobacterales in Latin America – by Paula Samper Escobar ...
more